Neil Moat, one of the busiest British surgeons involved directly and consistently in TAVR, discusses PARTNER 2 and SURTAVI, paying particular attention to the health economics of low-risk TAVR and the implication of reduced profile devices.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
March 31, 2016
The fourth (re- )classification of cardiopericardial tumours came from the World Health Organisation last year, 11 years after the third. In particular, the malignant fibrous histiocytomas are re classified as undifferentiated pleomorphic sarcomas.
Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction: The PREDICTS Study
March 23, 2016
Guidelines recommend that ICDs should not be implanted until after 90 days following revascularization in patients with an EF<35% and an MI. Studies have shown that no clinical benefit or detriment was derived by implantation prior to 90 days.
March 11, 2016
The authors provide an excellent overview of the rationale for screening all patients with a new diagnosis of cardiomyopathy for coronary artery disease. This rationale includes the following:
Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the PREVENT IV Trial
December 16, 2015
PREVENT IV trial participants who had undergone either a RIMA or LIMA to LAD anastomosis and underwent an angiogram at 1 to 1.5 years (n=1539) were analyzed for mammary graft failure (defined as >75% stenosis).
The Society of Thoracic Surgeons Clinical Practice Guidelines on Arterial Conduits for Coronary Artery Bypass Grafting
December 10, 2015
A growing body of evidence demonstrates improved short, mid, and long term outcomes with the use of arterial conduits for coronary revascularization. Despite this, less than 10% of patients receive more than 2 arterial grafts.
November 17, 2015
The authors report on the extended follow-up of Courage Trial patients for up to 15 years. In this trial, patients with chronic stable angina were randomized to medical therapy alone versus PCI plus medical therapy. At extended follow-up, there was no difference in overall survival between the two treatment strategies.
Comparative Histology of Aortic Dilatation Associated With Bileaflet Versus Trileaflet Aortic Valves
September 9, 2015
Resected aortas associated with a bicuspid aortic valve (BAV,n = 60) and trileaflet aortic valve (n = 24) in patients with aortic valve disease were compared with normal diameter aortas from patients undergoing cardiac transplantation (n = 16) by five histologic criteria.
Statistical and data reporting guidelines for the European Journal of Cardio-Thoracic Surgery and the Interactive CardioVascular and Thoracic Surgery
July 23, 2015
The paper presents the guidelines for authors on statistical and data reporting for the European Journal of Cardio-Thoracic Surgery (EJCTS) and the Interactive CardioVascular and Thoracic Surgery (ICVTS). It focusses on issues which are most frequently commented on by the statistical reviewers.
April 4, 2015
This multicenter randomized trial examined restrictive versus liberal threshold in red-cell transfusion in patients after cardiac surgery. The results were provocative, with more deaths in the restrictiv group compared to the liberal transfusion group. Posoperative complications were also slightly higher in the restrictive group.